Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
RBM14 Antibody, COAA Antibody, Paraspeckle protein 2 Antibody, RNA-binding motif protein 14 Antibody, RNA-binding protein 14 Antibody, SIP Antibody, TMEM137 Antibody, Transmembrane protein 137 Antibody, PSP2 Antibody, SYT-interacting protein Antibody, RNA binding motif protein 14 Antibody, SYTIP1 Antibody
COAA / RBM14 is a ribonucleoprotein that functions as a general nuclear coactivator, and an RNA splicing modulator. This protein contains two RNA recognition motifs (RRM) at the N-terminus, and multiple hexapeptide repeat domain at the C-terminus that interacts with thyroid hormone receptor-binding protein (TRBP), and is required for transcription activation.
RBM14 Antibody immunohistochemistry of formalin-fixed and paraffin-embedded human brain tissue followed by peroxidase-conjugated secondary antibody and DAB staining.
RBM14 Antibody western blot of Jurkat cell line lysates (35 ug/lane). The RBM14 antibody detected the RBM14 protein (arrow).
RBM14 Antibody flow cytometry of Jurkat cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated donkey-anti-rabbit secondary antibodies were used for the analysis.